Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha
Emanuel Marques, Petr Arenberger, Alžběta Smetanová, Spyridon Gkalpakiotis, Denisa Zimová, Monika Arenbergerová
Topics & Concepts
Hidradenitis suppurativaMedicineAlpha (finance)Tumor necrosis factor alphaNecrosisDermatologyCancer researchImmunologyPathologySurgeryDiseasePatient satisfactionConstruct validityHidradenitis Suppurativa and TreatmentsColorectal and Anal CarcinomasChemotherapy-related skin toxicity